GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » EV-to-EBIT

MustGrow Biologics (TSXV:MGRO) EV-to-EBIT : 89.70 (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MustGrow Biologics's Enterprise Value is C$47.09 Mil. MustGrow Biologics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.53 Mil. Therefore, MustGrow Biologics's EV-to-EBIT for today is 89.70.

The historical rank and industry rank for MustGrow Biologics's EV-to-EBIT or its related term are showing as below:

TSXV:MGRO' s EV-to-EBIT Range Over the Past 10 Years
Min: -140.27   Med: -119.7   Max: 89.7
Current: 89.7

During the past 8 years, the highest EV-to-EBIT of MustGrow Biologics was 89.70. The lowest was -140.27. And the median was -119.70.

TSXV:MGRO's EV-to-EBIT is ranked worse than
95.63% of 183 companies
in the Agriculture industry
Industry Median: 14.3 vs TSXV:MGRO: 89.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MustGrow Biologics's Enterprise Value for the quarter that ended in Dec. 2023 was C$60.33 Mil. MustGrow Biologics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.53 Mil. MustGrow Biologics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.87%.


MustGrow Biologics EV-to-EBIT Historical Data

The historical data trend for MustGrow Biologics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics EV-to-EBIT Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -10.75 -14.77 -60.37 -30.51 -89.11

MustGrow Biologics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.39 -30.51 -24.58 -19.89 -89.11

Competitive Comparison of MustGrow Biologics's EV-to-EBIT

For the Agricultural Inputs subindustry, MustGrow Biologics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MustGrow Biologics's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, MustGrow Biologics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MustGrow Biologics's EV-to-EBIT falls into.



MustGrow Biologics EV-to-EBIT Calculation

MustGrow Biologics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=47.090/0.525
=89.70

MustGrow Biologics's current Enterprise Value is C$47.09 Mil.
MustGrow Biologics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MustGrow Biologics  (TSXV:MGRO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MustGrow Biologics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=0.525/60.330044
=0.87 %

MustGrow Biologics's Enterprise Value for the quarter that ended in Dec. 2023 was C$60.33 Mil.
MustGrow Biologics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MustGrow Biologics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MustGrow Biologics (TSXV:MGRO) Business Description

Traded in Other Exchanges
Address
1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines